Skip to content

The effectiveness of virtual reality technology for auxiliary analgesia in scar laser therapy

The effectiveness of virtual reality technology for auxiliary analgesia in scar laser therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100915
Enrollment
Unknown
Registered
2025-04-17
Start date
2024-04-11
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar therapy

Interventions

Experimental group:Use VR (virtual reality) devices
Control group:None

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient age>=18 years old; Gender is not limited; 2. Scar area =4 points; 4. Patients who are able to understand the purpose of the study, voluntarily participate in and sign the informed consent form, and are willing to complete the follow-up as required by the protocol.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment; 2. Current or previous diagnosis of epilepsy, dementia, migraine or other neurological diseases that may cause inability to use VR software or possible adverse effects; 3. Presence of conditions sensitive to light stimuli; 4. No stereopsis or severe hearing impairment; 5. There is a condition that may cause injury to the eyes, face or neck, and hinder the use of VR equipment; 6. Severe heart, liver, kidney, blood, digestive, nervous system diseases and malnutrition; 7. Is receiving or plans to receive long-acting analgesic therapy or minimally invasive interventional therapy; 8. Have a history of severe alcohol abuse, or drink heavily for a long time, or have symptoms of alcohol dependence; 9. Current or recent participation (within 1 week) in any analgesic interventional study; 10. Are pregnant or plan to become pregnant during the study; 11. Other situations that the investigator considers unsuitable for participating in clinical trials.

Design outcomes

Primary

MeasureTime frame
Virtual reality technology used in scar laser treatment for analgesi;

Secondary

MeasureTime frame
Incidence of adverse events and serious adverse events;

Countries

China

Contacts

Public Contactshiyan

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

18516130422@163.com+86 18516130422

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026